期刊
MOLECULAR GENETICS AND METABOLISM REPORTS
卷 38, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.ymgmr.2023.101023
关键词
Cerebral folate deficiency; Cerebral folate; Folinic acid; Spastic paraplegia 56; 5-methyltetrahydrofolate; 5-MTHF
With the rapid advancement of medical technologies, the number of treatable neurometabolic diseases is increasing. This study reports two Chinese brothers with bi-allelic pathogenic variants in the CYP2U1 gene who were treated with folinic acid supplement for over a decade and remained stable under therapy.
With the rapid advancement of medical technologies in genomic and molecular medicine, the number of treatable neurometabolic diseases is quickly expanding. Spastic paraplegia 56 (SPG56), one of the severe autosomal recessive forms of neurodegenerative disorders caused by pathogenic variants in the CYP2U1 gene, has no reported specific targeted treatment yet. Here we report 2 Chinese brothers with CYP2U1 bi-allelic pathogenic variants with cerebral folate deficiency who were treated for over a decade with folinic acid supplement. Patients have remained stable under therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据